Leaders in oncology share why the American Society of Clinical Oncology (ASCO) meeting remains a top global gathering for breakthroughs, networking, and lifelong learning.
Danny Rischin, MD
Advertisement
Medical oncologist, clinician researcher, Peter McCallum Cancer Centre.
Articles by Danny Rischin, MD
Danny Rischin, MD, medical oncologist, clinician researcher, Peter McCallum Cancer Centre, discusses a novel adjuvant treatment approach for patients with locally advanced cutaneous squamous cell carcinoma (CSCC).
Cemiplimab significantly enhances disease-free survival in high-risk cSCC patients, reducing recurrence and metastasis risks, according to findings presented at ASCO.
Advertisement
Latest Updated Articles
SPOTLIGHT: Cemiplimab Shows Promising Results in Adjuvant Treatment for cSCCPublished: June 1st 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
2
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
3
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
4
Efgartigimod Outperforms Standard IVIG in Averting Myasthenic Crisis
5
